Huida Gene: HuidaGene Therapeutics Announces Publication of the World's First Guanine Base-Editor
SHANGHAI and CLINTON, N.J., May 18, 2023 /PRNewswire/ -- HuidaGene Therapeutics (????; HuidaGene), a clinical-stage genome-editing company, today announced the online National Science Review publi...
Read full article »
Huida Gene is a China-based clinical-stage biotechnology company that researches and develops CRISPR-based genetic medicines for the treatment of rare monogenic disorders.
Read more